COPD

Phase 3 trial initiated for investigational oral COPD therapy
Verducatib is a treatment option targeting dipeptidyl peptidase 1 in adult COPD patients.
November 12, 2026
Medical professionals in white coats discuss patient care in a modern laboratory or clinical setting with imaging software visible on monitors.
Merck begins phase 3 study for ensifentrine COPD treatment
Ensifentrine is the first and only novel inhaled mechanism for the maintenance treatment of COPD in more than 20 years to combine bronchodilation and non-corticosteroid anti-inflammatory effects.
November 12, 2026
Female scientist in white lab coat examining sample in modern laboratory with equipment and chemical bottles
FDA grants clearance for treprostinil soft mist inhaler clinical trial
The new application could be the first approved treatment for pulmonary hypertension associated with COPD.
November 4, 2026
Teal asthma inhaler held in hand dispensing medication against dark background
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
COPD treatment falls short in phase 2 proof-of-concept trial
Fexlamose did not demonstrate improvements in FEV1, FVC or other spirometric measures in patients with COPD.
November 4, 2026
Hand writing 'Proof of Concept' in white chalk on a blackboard
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The treatment was particularly effective in high-dose courses among those with type 2 inflammation.
October 29, 2026
3D neon illustration of human lungs with blood vessels and highlighted virus particle on dark blue background
Study reveals BMI's limitations in predicting COPD risk
Research suggests a more disease-specific approach to obesity assessment and weight management is warranted.
October 29, 2026
Doctor measuring patient's waist with yellow tape measure during health checkup
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
Advocate for better air
Global burden of COPD-associated heart failure is on the rise
A review of data from the Global Burden of Disease Study found China has the highest national burden, and worldwide prevalence is projected to double by 2050.
October 21, 2026
Elderly man relaxing on a purple floral sofa with a small dog beside him and potted flowers nearby
Data add support of tozorakimab for COPD
Analysis from three key trials reinforces benefits to COPD patients across all blood eosinophil counts and stages of lung function severity.
October 21, 2026
Healthcare professional workspace with stethoscope, medical charts, smartphone, and digital health technology icons
Dosing begins in trial of novel COPD therapy
KIT2014 is an innovative, inhaled peptide therapy that was developed for COPD and other respiratory illnesses.
October 16, 2026
Digital medical visualization of glowing lungs in human body with health monitoring data panels and vital signs displays
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
Chronic respiratory disease burden on the rise in Western Pacific region
World Health Organization analysis finds COPD accounted for 75.3% of CRD-related disability-adjusted life years in 2023.
October 16, 2026
Vintage globe map showing Southeast Asia, Indonesia, Australia, and surrounding regions with geographical labels and a ruler overlay
Regular walking helps patients with COPD in areas of high air pollution
Researchers found that exercise was associated with fewer symptom flareups, regardless of local levels of pollution.
October 8, 2026
Woman jogging on outdoor path wearing olive green jacket, experiencing chest discomfort while running
COPD treatment delivers positive preliminary results in phase 2 trial
Rademikibart significantly reduced the rate of hospitalizations or emergency department visits for new acute COPD exacerbations by 100%.
October 8, 2026
Female scientist using microscope in modern laboratory with laptop and equipment
Page 1 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial